Trends in Pharmacological Sciences 1997 - Abstracts
| Trends in Pharmacological Sciences 1997 | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| Agonist-specific receptor conformations.(Forum) | Pharmaceuticals and cosmetics industries | Kenakin, Terry | |||
| Anaesthetics in a bind? | Pharmaceuticals and cosmetics industries | Peters, John A., Lambert, Jeremy J. | |||
| Any facts behind the DHEA hype? (dehydroepiandrosterone) | Pharmaceuticals and cosmetics industries | Quirion, Remi, Bastianetto, Stephane | |||
| Association of beta3-adrenoceptor polymorphism with obesity and diabetes: current status. | Pharmaceuticals and cosmetics industries | Strosberg, A. Donny | |||
| Bcl-2 related proteins, apoptosis and disease. | Pharmaceuticals and cosmetics industries | Anderson, Gary P. | |||
| Changing the countenance of pharmacology courses in medical schools.(Education) | Pharmaceuticals and cosmetics industries | Rodriguez, Rodolfo, Vidrio, Horacio, Martinez, Enrique-Lopez, Contreras, Eusebio, Valenzuela, Fermin | |||
| Clinical development of endothelin receptor antagonists.(Meeting Report) | Pharmaceuticals and cosmetics industries | Douglas, Stephen A. | |||
| Cortical and limbic dopamine (on opiate addiction): do not mix before use! | Pharmaceuticals and cosmetics industries | Di Chiara, Gaetano | |||
| Four Beta-adrenoceptor subtypes in the mammalian heart. | Pharmaceuticals and cosmetics industries | Kaumann, Alberto J. | |||
| G protein interaction with K+ and Ca2+ channels. | Pharmaceuticals and cosmetics industries | Schneider, T., Hescheler, J., Igelmund, P. | |||
| Hans Walter Kosterlitz (1903-1996). (Obituary)(Obituary) | Pharmaceuticals and cosmetics industries | Henderson, Graeme | |||
| Human Genome Project Europe. (conference on genomic technology)(Meeting Report) | Pharmaceuticals and cosmetics industries | Bailey, David, Williamson, Alan R., Dykes, Colin W., Romanos, Mike | |||
| Investigation of receptors responsive to pyrimidines.(Comment)(Column) | Pharmaceuticals and cosmetics industries | Duley, John A., Connolly, Gerald P., Abbott, N. Joan, Demaine, Cedric | |||
| In vivo studies with antisense oligonucleotides. | Pharmaceuticals and cosmetics industries | Akhtar, Saghir, Agrawal, Sudhir | |||
| Ionotropic glutamate receptors: new types and new concepts. | Pharmaceuticals and cosmetics industries | Barnard, Eric A. | |||
| Is the R and R* dichotomy real? (active and inactive receptors of G proteins interactions)(Forum) | Pharmaceuticals and cosmetics industries | Tucek, Stanislav | |||
| Low-voltage-activated T-type Ca2+ channels. | Pharmaceuticals and cosmetics industries | Ertel, Sylvie I., Ertel, Eric A. | |||
| Metabotropic GABA(sub B) receptors cloned at last. | Pharmaceuticals and cosmetics industries | Bowery, Norman G. | |||
| More on the classification of cysteinyl leukotriene receptors: subclassification of CysLT1 and CysLT2 receptors based on endogenous liquids. (response to I. Gorenne, Trends in Pharmacological Sciences, vol. 17, p. 342, 1996)(includes reply)(Letter to the Editor) | Pharmaceuticals and cosmetics industries | Rovati, G.E., Capra, V., Nicosia, S. | |||
| NF-kB: a pivotal role in asthma and a new target for therapy. | Pharmaceuticals and cosmetics industries | Barnes, Peter J., Adcock, Ian M. | |||
| Nitric oxide: inducer or suppressor of apoptosis? | Pharmaceuticals and cosmetics industries | Nicotera, Peirluigi, Brune, Bernhard, Bagetta, Giacinto | |||
| On criteria for functional beta3-adrenoreceptors. (questions on the reliability of stereoselectivity as a criterion) | Pharmaceuticals and cosmetics industries | Kaumann, Alberto J., Molenaar, Peter | |||
| Oxygen-sensitive ion channels.(Current Awareness) | Pharmaceuticals and cosmetics industries | Peers, Chris | |||
| Potassium channels still hot. (1997 International Potassium Channel Conference) | Pharmaceuticals and cosmetics industries | Grissmer, Stephan | |||
| Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity. | Pharmaceuticals and cosmetics industries | Lazarowski, Eduardo R., Boucher, Richard C., Harden, T. Kendall | |||
| Release of soluble nucleotidases: a novel mechanism for neurotransmitter inactivation? | Pharmaceuticals and cosmetics industries | Kennedy, Charles, Todorov, Latchezar D., Mihaylova-Todorova, Svetlana, Sneddon, Peter | |||
| Royal Society Muller Award. (1997)(Grants And Awards) | Pharmaceuticals and cosmetics industries | ||||
| The 5-HT(sub 7) receptor: orphan found. (5-hydroxytryptamine) | Pharmaceuticals and cosmetics industries | Eglen, Richard M., Jasper, Jeffrey R., Chang, David J., Martin, Graeme R. | |||
| The cross-talk between nitric oxide and Ca2+: a story with a complex past and a promising future. | Pharmaceuticals and cosmetics industries | Meldolesi, Jacopo, Clementi, Emilio | |||
| The dual nature of the tachykinin NK(sub 1) receptor. (includes related article on active conformers of the NK(sub 1) receptor) | Pharmaceuticals and cosmetics industries | Schwartz, Thue W., Maggi, Carlo A. | |||
| The Institute of Pharmacology of Sherbrooke: a first in Canada. | Pharmaceuticals and cosmetics industries | Battistini, Bruno | |||
| The interaction between salmeterol and the beta2-adrenoceptor protein: salmeterol irreversibly binds to the hydrophobic core of the seven transmembrane protein. (response to R.A. Coleman, Trends in Pharmacological Sciences, vol. 17, p. 324, 1996)(includes reply) | Pharmaceuticals and cosmetics industries | Jack, David | |||
| The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. | Pharmaceuticals and cosmetics industries | Striessnig, Jorg, Moebius, Fabian F., Glossman, Hartmut | |||
| The role of excitotoxicity in organophosphorous nerve agents central poisoning. | Pharmaceuticals and cosmetics industries | Belkin, Michael, Solberg, Yoram | |||
| Thiopurine biology and pharmacology. | Pharmaceuticals and cosmetics industries | Janka-Schaub, Gritta, Aarbakke, Jarle, Elion, Gertrude B. | |||
| Time to reassess chiral aspects of beta-adrenoceptor antagonists: clinical evidence for harmful effects of the non-beta-blocking enantiomers.(Comment) | Pharmaceuticals and cosmetics industries | Stoschitzky, Kurt, Klein, Werner, Linder, Wolfgang | |||
| TiPS Receptor and Ion Channel Nomenclature Supplement 1997. | Pharmaceuticals and cosmetics industries | Mead, Annette, Babbedge, Rachel | |||
| Towards a revised nomenclature for P1 and P2 receptors. | Pharmaceuticals and cosmetics industries | Williams, Michael (British actor), Burnstock, Geoffrey, Jacobson, Kenneth A., Harden, T. Kendall, Fredholm, Bertil B., Abbracchio, Maria P., Dubyak, George R., Schwabe, Ulrich | |||
| What is pharmacology? A discussion. | Pharmaceuticals and cosmetics industries | Laurence, Desmond | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.